Key Clinical Summary
A multicenter Italian real-world study of 868 patients with psoriatic arthritis found durable long-term retention of interleukin-17 (IL-17) inhibitors, with overall retention of 77.5% at 12 months and 52.1% at 36...
Key Clinical Summary
A multicenter Italian real-world study of 868 patients with psoriatic arthritis found durable long-term retention of interleukin-17 (IL-17) inhibitors, with overall retention of 77.5% at 12 months and 52.1% at 36...
Key Clinical Summary
A longitudinal cohort study published in Rheumatology found radiographic damage repair in 29.7% of patients with psoriatic arthritis (PsA) who developed structural joint damage during 7,189.5...
Key Clinical Summary
A longitudinal cohort study published in Rheumatology found radiographic damage repair in 29.7% of patients with psoriatic arthritis (PsA) who developed structural joint damage during 7,189.5...
The meta-analysis found no evidence that either TNFi cycling or switching to a biologic with a different mechanism offers superior effectiveness or safety after initial TNFi failure in psoriatic arthritis.
The meta-analysis found no evidence that either TNFi cycling or switching to a biologic with a different mechanism offers superior effectiveness or safety after initial TNFi failure in psoriatic arthritis.
The identification of a circulating serum miRNA signature may offer a noninvasive strategy to improve diagnostic discrimination between rheumatoid arthritis and psoriatic arthritis.
The identification of a circulating serum miRNA signature may offer a noninvasive strategy to improve diagnostic discrimination between rheumatoid arthritis and psoriatic arthritis.
Meta-regression showed a lower rate of incident cardiovascular disease in more recent data for patients with psoriatic arthritis, but not for patients with spondyloarthritis, researchers report.
Meta-regression showed a lower rate of incident cardiovascular disease in more recent data for patients with psoriatic arthritis, but not for patients with spondyloarthritis, researchers report.
Dr Paudel reviews research she and colleagues conducted to validate the EULAR definition of difficult-to-treat rheumatoid arthritis, and differences among patients with difficult-to-treat RA versus those with controlled disease.
Dr Paudel reviews research she and colleagues conducted to validate the EULAR definition of difficult-to-treat rheumatoid arthritis, and differences among patients with difficult-to-treat RA versus those with controlled disease.
